{"url_path":"/sec/rnaz/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 ****Unregistered Sales of Equity Securities and Use of Proceeds**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1829635/0001104659-26-062535-index.html","accession_number":"0001104659-26-062535","cik":"0001829635","ticker":"RNAZ","issuer_name":"Transcode Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1829635/0001104659-26-062535-index.html","primary_entity_key":"0001829635","primary_entity_name":"Transcode Therapeutics, Inc."},"word_count":35,"has_tables":true,"body_markdown":"**ITEM 2.****Unregistered Sales of Equity Securities and Use of Proceeds**\n\n**(a)****Unregistered Sales of Equity Securities**\n\nNone.\n\n**(b)****Use of Proceeds from Initial Public Offering of Common Stock**\n\nNot applicable.\n\n**(c)****Issuer Purchases of Equity Securities**\n\nNone.\n\n​"}